Moreover, isatuximab promotes internalization into CD38high cells, leading to lysosomal enlargement and protease-mediated degradation of FOXM1, a transcription factor essential for the proliferation and redox homeostasis of 1q+ MM cells. This evidence concerns the gene FOXM1 and Miyoshi myopathy.